Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Methods (San Diego, Calif.)
|
May 19, 2015
Cerebrospinal fluid protein dynamic driver network: At the crossroads of brain tumorigenesis
Zhou Tan, Rui Liu, Le Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2018
Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors
David M Hyman, Naiyer Rizvi, Ronald Natale, et al.
Scientific Reports
|
August 19, 2020
High levels of ubidecarenone (oxidized CoQ<sub>10</sub>) delivered using a drug-lipid conjugate nanodispersion (BPM31510) differentially affect redox status and growth in malignant glioma versus non-tumor cells
Jiaxin Sun, Chirag B Patel, Taichang Jang, et al.
Plos One
|
October 11, 2019
A proteomic clock for malignant gliomas: The role of the environment in tumorigenesis at the presymptomatic stage
Le Zheng, Yan Zhang, Shiying Hao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2016
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O<sup>6</sup>-Methylguanine-DNA Methyltransferase Biomarker Analyses
Timothy Cloughesy, Gaetano Finocchiaro, Cristóbal Belda-Iniesta, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 4, 2008
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial
Minesh P Mehta, William R Shapiro, See C Phan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 6, 2011
Central nervous system cancers
Steven S Brem, Philip J Bierman, Henry Brem, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 14, 2013
Central nervous system cancers
Louis Burt Nabors, Mario Ammirati, Philip J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2014
Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines
Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 21, 2015
Central Nervous System Cancers, Version 1.2015
Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Methods (San Diego, Calif.)
|
May 19, 2015
Cerebrospinal fluid protein dynamic driver network: At the crossroads of brain tumorigenesis
Zhou Tan, Rui Liu, Le Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2018
Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors
David M Hyman, Naiyer Rizvi, Ronald Natale, et al.
Scientific Reports
|
August 19, 2020
High levels of ubidecarenone (oxidized CoQ<sub>10</sub>) delivered using a drug-lipid conjugate nanodispersion (BPM31510) differentially affect redox status and growth in malignant glioma versus non-tumor cells
Jiaxin Sun, Chirag B Patel, Taichang Jang, et al.
Plos One
|
October 11, 2019
A proteomic clock for malignant gliomas: The role of the environment in tumorigenesis at the presymptomatic stage
Le Zheng, Yan Zhang, Shiying Hao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2016
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O<sup>6</sup>-Methylguanine-DNA Methyltransferase Biomarker Analyses
Timothy Cloughesy, Gaetano Finocchiaro, Cristóbal Belda-Iniesta, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 4, 2008
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial
Minesh P Mehta, William R Shapiro, See C Phan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 6, 2011
Central nervous system cancers
Steven S Brem, Philip J Bierman, Henry Brem, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 14, 2013
Central nervous system cancers
Louis Burt Nabors, Mario Ammirati, Philip J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2014
Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines
Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 21, 2015
Central Nervous System Cancers, Version 1.2015
Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Page
of 5